Nova Eye Medical Ltd
ASX:EYE

Watchlist Manager
Nova Eye Medical Ltd Logo
Nova Eye Medical Ltd
ASX:EYE
Watchlist
Price: 0.19 AUD 11.76% Market Closed
Market Cap: AU$54.1m

Net Margin

-31%
Current
Improving
by 25.7%
vs 3-y average of -56.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-31%
=
Net Income
AU$-9.1m
/
Revenue
AU$29.3m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-31%
=
Net Income
AU$-9.1m
/
Revenue
AU$29.3m

Peer Comparison

Country Company Market Cap Net
Margin
AU
Nova Eye Medical Ltd
ASX:EYE
54m AUD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.5B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
185.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
136.5B USD
Loading...
US
Stryker Corp
NYSE:SYK
134.8B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.7B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.6B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.7B USD
Loading...

Market Distribution

In line with most companies in Australia
Percentile
50th
Based on 4 004 companies
50th percentile
-31%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Nova Eye Medical Ltd
Glance View

Market Cap
54.1m AUD
Industry
Health Care

Nova Eye Medical Ltd. engages in developing suite of novel ophthalmic treatment technologies. The company is headquartered in Adelaide, South Australia and currently employs 130 full-time employees. The firm is focused on developing, manufacturing and selling a portfolio of ophthalmic treatment technologies and devices. Its technologies include iTrack minimally invasive glaucoma surgery (MIGS), which is a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patients' reliance on anti-glaucoma medications for mild-moderate glaucoma. Its Molteno3 glaucoma drainage device platform is designed to manage surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma. The firm's 2RT is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD).

EYE Intrinsic Value
0.29 AUD
Undervaluation 33%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-31%
=
Net Income
AU$-9.1m
/
Revenue
AU$29.3m
What is Nova Eye Medical Ltd's current Net Margin?

The current Net Margin for Nova Eye Medical Ltd is -31%, which is above its 3-year median of -56.7%.

How has Net Margin changed over time?

Over the last 3 years, Nova Eye Medical Ltd’s Net Margin has increased from -55.9% to -31%. During this period, it reached a low of -89.3% on Jun 30, 2023 and a high of -31% on Jun 30, 2025.

Back to Top